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Abstract: The article discusses the application of vibrational spectroscopy techniques for in vivo identification and   
characterization of glucose biomolecules monitored in the skin of healthy, prediabetes and diabetes subjects; for   
molecular characterization of water and proteins in in vivo monitored patch tested inflamed skin of the patients with  
contact dermatitis; for description of nucleic acids and proteins at the molecular level with progression to malignancy in  
skin cancerous lesions. The results of the studies show new possibilities to assess activity levels of glucose metabolism in  
the skin tissue of healthy, prediabetes and diabetes subjects; activity and severity of inflammation; activity of the   
processes of carcinogenesis with regard to benign, premalignant and malignant transformation. Based on our findings, we  
suggest that vibrational spectroscopy might be a rapid screening tool with sufficient sensitivity and specificity to identify and  
characterize skin biomolecules in described diseases for drug targeting and monitoring by the pharmacological community. 
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INTRODUCTION 
  Vibrational spectroscopy, both infrared (IR) and Raman, 
is a well-known structural and analytical laboratory method, 
because of the high sensitivity of vibrational spectra to   
characterize structures of biological molecules – water,   
proteins, nucleic acids, lipids, carbohydrates, etc. [1]. Due to  
the fact that IR and Raman spectroscopies are also highly  
sensitive to detect structural changes with the diseased state,  
vibrational spectroscopy has recently received much   
attention from the medical community, including   
dermatology, as a new promising tool for rapid,   
highly-informative, non-destructive, qualitative and (semi-)  
quantitative molecular characterization of normal and   
pathological tissues in vitro, ex vivo and in vivo [1-7]. 
  The skin is a very complex and heterogeneous tissue. 
However, as the human body, on a simple level, is composed 
primarily of biomolecules of water, proteins, nucleic acids, 
lipids and carbohydrates, the relative ratios and the absolute 
concentrations of each of them can be determined in vibra-
tional spectra. 
  Isolated biomolecules of the nucleic acids, water, pro-
teins, lipids, carbohydrates and others have been intensively 
studied and well-described by vibrational spectroscopy tech-
niques [1]. 
  IR spectroscopy has an advantage to identify and   
characterize nucleic acids, in comparison to Raman   
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spectroscopy, which provides information related to individual 
nucleotides only. So, IR spectra in the 1620-1750 cm
-1 region 
corres-ponds to in-plane double-bond vibrations of the bases; 
the 1230 cm
-1 and 1090 cm
-1 bands are assigned to antisym-
metric and symmetric phosphate stretching vibrations, re-
spectively; ribose has a strong C-O band at 1120 cm
-1 [1, 3]. 
  Both IR and Raman provide information on the secon-
dary structure of proteins, ligand interactions and folding. In 
the vibrational spectra, amide I in the 1600-1700 cm
-1 region 
is by far the best characterized, which is due mostly to the 
C=O stretching vibrations of the peptide backbone. The   
amide II band in the 1480-1575 cm
-1 region, due largely to a 
coupling of CN stretching and in-plane bending of N-H 
group, is strong in IR, but extremely weak in Raman. The 
amide III band in the 1230-1300 cm
-1 region, arising from 
coupling of C-N stretching and N-H bending, is fairly weak 
in IR but quite strong in Raman [1, 3]. 
  The major absorption bands of lipids are at 1738, 1465, 
1255, 1168, 1095, 1057 and 968 cm
-1 [1, 3]. 
  Sugars are the most common carbohydrates. They are 
presented in biological media primarily as hexose sugars, 
such as glucose, and as pentose sugars, mainly as the ribose 
component of the nucleic acid backbone of DNA and RNA. 
Polysaccharides in the body are found either in a free state or 
combined with proteins, in a complex known as glycopro-
teins. The only polysaccharide in the body that is not bound 
to a protein is glycogen, the spectrum of which is highly de-
pendent on the degree of hydration. The major absorption 
bands of glycogen in solution are observed in IR spectra at 
1153, 1105, 1082, 1043, 1025, 996 (weak shoulder) and 931 
cm
-1. The corresponding bands for the solid spectrum are Identification and Characterization of Skin Biomolecules  The Open Medicinal Chemistry Journal, 2008, Volume 2    39 
1149, 1078, 1043 (weak shoulder), 1016, 996 and 931 cm
1 
[1]. 
  As a consequence of the complexity of skin tissue, com-
prising several components and various cell types, the band 
assignment of different biomolecules in vibrational spectra 
of the skin is difficult, especially in the diseased state, be-
cause it is influenced by numerous intermolecular interac-
tions. Therefore, it is important not only to identify (facili-
tate) and compare the band assignment of spectra of major 
constituents of skin and its compounds in normal and patho-
logical tissue, but also to molecularly characterize them with 
regard to numerous skin diseases and conditions. Since all 
diseased states and conditions, without exception, are caused 
by fundamental alterations in cellular and/or tissue bioche-
mistry due to specific changes in one or all biomolecular 
components, then these changes should be reflected in vibra-
tional spectra and, in principle, may to be further used as 
phenotypic markers of the diseases for diagnoses, drug tar-
geting and monitoring [1, 6]. 
  Such an approach would be much needed in the new 
fields of applications, such as the individualization of drug or 
treatment in certain diseases and monitoring the effects of 
therapies, based on the already demonstrated potential of IR 
and Raman spectroscopies to non-invasively diagnose and 
continuously monitor patients in the clinical environment. At 
a more fundamental level, the in-depth analysis of the wealth 
of information contained in IR- and Raman spectra of certain 
skin diseases about specific molecular composition and 
structure can be used not only to further explore pathological 
processes and their progression, but also to further transform 
for directing real-time therapeutic intervention. 
  In this article we discuss the state of the art of applying 
vibrational spectroscopy techniques for in vivo identification 
and characterization of glucose biomolecules monitored in 
the skin of healthy, prediabetes and diabetes subjects; for 
molecular characterization of water and protein biomolecules 
in in vivo monitored patch tested inflamed skin of the pa-
tients with contact dermatitis; for description of nucleic acids 
and proteins at the molecular level with progression to ma-
lignancy in skin cancerous lesions. The intended reader is 
directed to recent review and research articles that address 
these issues in more detail [3, 8-11]. Rather, we would like 
to take the perspective of the intended end user of described 
vibrational spectroscopy techniques from pharmaceutical 
community. The path toward implementing vibrational spec-
troscopy technique for molecular drug targeting and moni-
toring is discussed, based on how far have we progressed in 
our studies. 
SUBJECTS AND METHODOLOGY 
  Very few vibrational spectroscopy techniques have been 
translated into patient`s health care in dermatological clinics, 
in spite of the rapid developments and progress in technology 
for using them in laboratories [10]. Mainly, it is because 
measuring of the skin requires certain technical prerequisites, 
like availability of remote fiber optic probes able to measure at 
any anatomical location, availability of the desired measuring 
aperture area in the used instrumentation, short measuring 
time, appropriate wavelength for laser light excitation in order 
to overcome skin tissue autofluorescence, and measurement of 
skin spectra with a high (adequate) signal-to-noise ratio 
(SNR). Moreover, it is important to use an appropriate method 
with desired depth penetration of skin tissue for the study, so 
that it is relevant with regard to the skin layer origin of inves-
tigated disease or a (patho-)physiological condition in question 
[3, 8, 10]. Based on these issues, the FT-IR spectroscopy with 
the ATR (attenuated total reflection) accessory was chosen for 
our study to in vivo identify and characterize glucose bio-
molecules in monitored skin of healthy, prediabetes and diabe-
tes subjects; NIR FT Raman spectroscopy technique with a 
remote fiber optic probe to molecularly characterize and in 
vivo monitor skin inflammation on the back of patch tested 
patients with contact dermatitis; and FT-IR spectroscopy with 
a microscope accessory to in vitro characterize spectra of be-
nign, premalignant and malignant skin lesions at the molecular 
level, which is discussed below in detail. 
ATR-FTIR Spectroscopy for Real-Time Non-Invasive 
Skin Glucose Characterization and Monitoring 
  A high throughput ATR accessory, the PIKE Technolo-
gies Horizontal ATR (HATR) (ATR-8200 HA), is designed 
for use in commercially available Shimadzu FTIR spec-
trometer (Shimadzu IRPrestige-21/FTIR-8400S, Japan). The 
ATR accessory is available with two basic types of mounted 
crystal, the trough plate and the flat plate, both is of a trape-
zoid shape and is 80 mm long, 10 mm wide and 4 mm thick. 
This thickness of the crystal was carefully chosen by manu-
facturer in order to produce optimum performance from the 
accessory, and the crystal dimensions have been chosen to 
maximize SNR in the resulting spectra. To perform in vivo 
measurements from the inner wrists of the subjects, the flat 
plate has been used for the collection of mid-infrared spectra 
in our study. Before each measurement the spectrum was 
obtained by rationing a scan measured from the inner wrist 
area to a background scan. In vivo infrared ATR spectra were 
recorded in the 700-4000 cm
-1 wavenumber region at a reso-
lution of 4 cm
-1, using number 20 of accumulation for the 
collection of interferogram. 
  Eleven subjects participated in the study: one with diabe-
tes (type 2); three, as suspects of having impaired glucose 
tolerance (prediabetes), due to randomly measured post-
prandial hyperglycemia; and seven healthy subjects. The 
following measurements were done: 1) randomly, i.e. casu-
ally measured regardless of when the patient last ate; 2) on 
mornings, when a subject has refrained from eating for 10 to 
16 hours (fasting measurements); 3) measured from 1 to 3 
hours after a meal (postprandial measurements); 4) during 
OGTT (oral glucose tolerance test), after given orally a glu-
cose solution to drink, including 5 g (minimum dose), 20 g 
(medium dose) and/or 75 g (maximum dose, i.e. clinical test 
dose) of glucose. 
  All measurements by ATR-FTIR spectroscopy were per-
formed immediately after determining blood glucose level 
by a portable glucosemeter (SKK GluTestS, Sanwa Chemi-
cal Institute, Nagoya, Japan) in mg/dL. 40    The Open Medicinal Chemistry Journal, 2008, Volume 2  Eikje et al. 
  The techniques applied to treat in vivo HATR-FTIR spec-
tra included: 1) normalization to amide I; 2) multiple base-
line correction; 3) in the present study, the amide I band near 
1645 cm
-1 was considered constant, and therefore was used 
in calculating the intensities of the peaks at around 1030 cm
-1, 
1041 cm
-1, 1080 cm
-1, 1118 cm
-1 and 1153 cm
-1. 
Fiberoptic NIR FT Raman Spectroscopy for Direct Mo-
lecular Characterization and In Vivo Monitoring of In-
flammation in the Skin (Type IV Allergic Reaction) 
  Fiber optic NIR FT RFS 100-Raman spectrometer on a 
Bruker IFS 66 optics system (Bruker Analytik GmbH, 
Karlsruhe, Germany), equipped with a liquid nitrogen-cooled 
Ge detector, was using the excitation source of a 1064 nm 
line (virtually elicits almost no fluorescence) from a continu-
ous wave Nd:YAG laser at 200 mW. In vivo Raman spectra 
of normal control and skin reacting to patches (inflamed 
skin) on the back of the patients, as suspects of contact der-
matitis, were measured in 400-3500 cm
-1 region within 250 
scans by using a resolution of 8 cm
-1. 
  In the present study fiberoptic NIR FT Raman spectros-
copy was used to instrumentally assess 63 positive patch test 
(PT) reactions at 48 h and 72 h, at the time of their readings 
in a contact dermatitis clinic. The application of commer-
cially available allergens for 48 h was used to clinically re-
produce contact dermatitis, in miniature, in the patients sus-
pected to have this disease. The common method of clinical 
reading includes scoring into irritant, doubtful (+?; faint 
erythema only), weak (+; erythema, oedema, possibly pa-
pules), strong (++; erythema, oedema, papules, vesicles) and 
extremely strong (+++; intense erythema and oedema; coa-
lescing vesicles) positive PT reactions [12]. 
  For assessment of water content in the skin, the intensity 
of an O-H stretching mode of water at 3250 cm
-1, that is pre-
sented  in vivo Raman spectra in a broad feature between 
3100 and 3500 cm
-1, was used in the calculated ratio 
I3250/I2940 [13,14]. 
  The Wilcoxon Rank-Sum test, a nonparametric Mann-
Whitney U-test was used to compare different PT reaction 
groups at 48 h and 72 h. A value of p < 0.05 was considered 
to indicate a statistically significant difference. 
FT-IR Microspectroscopy for In Vitro Description of 
Skin Cancerous Tissue 
  An FT-IR microspectrometer (IR-MAU200, JEOL Co., 
Tokyo, Japan) was used to obtain spectra with a resolution of 
4 cm
-1 over a spectral range of 800-4000 cm
-1, using a knife 
edge aperture reduced to a 25  25 μm. Spectra of 47 normal 
and lesional, epidermal (Bowen`s disease, solar keratosis, 
basal cell carcinoma (BCC), squamous cell carcinoma 
(SCC), malignant melanoma (MM)) and dermal (intradermal 
nevus), skin components were acquired from a 6 μm cut-
sections on a CaF2 (calcium fluoride) slide glasses, with 
speed scans of 127 [15]. 
 
 
 
RESULTS 
ATR-FTIR Spectroscopy for In Vivo Identification, 
Characterization and Monitoring of Glucose Bio-
molecules in the Skin of Healthy, Prediabetes and Diabe-
tes Subjects 
  In all measured volunteers a closer assessment of the 
glucose-related region between 1000 and 1180 cm
-1 in ATR-
FTIR spectra found glucose-specific peaks at about 1030 
(±2-3) cm
-1, 1041 (± 4) cm
-1, 1080 (± 4) cm
-1, 1118 (- 7; + 4) 
cm
-1 and 1153 (± 4) cm
-1. 
 In  vivo spectra of monitored skin in 8 subjects during 
OGTT showed shifts, at most at 1041 cm
-1 and at 1118 cm
-1 
peaks, and at less at 1030 cm
-1, 1080 cm
-1 and at 1153 cm
-1 
peaks. Shifts to the left were more seen in healthy volunteers 
and shifts to the right were noticed in prediabetes and diabe-
tes subjects (see peak captions in Fig. 2a-c). 
 Fig.  (1) demonstrates examples of spectral variations of 
the intensity of the peaks at 1041 cm
-1 and at 1118 cm
-1 in 
the skin of the patients with type 2 diabetes, prediabetes and 
a healthy measured subject. In vivo spectra of all measured 
prediabetes and diabetes volunteers showed the prominence 
of the peak near 1118 cm
-1 over the peak intensity near 1041 
cm
-1, that was not seen in healthy subjects. Therefore, based 
on the differences of the intensities near peaks at 1041 cm
-1 
and at 1118 cm
-1, two spectral patterns could be seen: I1118 > 
I1041 for prediabetes and diabetes subjects, and I1118 < I1041 for 
non-diabetes subjects. These differences were seen inde-
pendently on the screening tests performed. 
  Real-time non-invasive monitoring of absorbances of the 
glucose peak near 1030 cm
-1 during a 4-hour OGTT after 
intake of a clinical dose of glucose (75 g) in the patient with 
type 2 diabetes demonstrates an ability to monitor glucose 
activity changes in the skin tissue by ATR-FTIR spectro-
scopy in vivo (Fig. 2). 
 Fig.  (3a-c) demonstrates examples of in vivo skin glucose 
monitoring based on calculated absorbances of glucose bio-
molecules at wavelengths of 1041 cm
-1, 1080 cm
-1, 1118 cm
-1 
and 1153 cm
-1 during a 1-hour OGTT (75 g) at a 15-min 
interval in a healthy, prediabetes and diabetes subjects. It 
also shows evidences of indirect correlation between the 
intensities of these peaks and blood glucose levels in a time-
dependent manner (Fig. 3d). During OGTT this in vivo 
monitoring revealed that specific for a healthy, prediabetes 
and diabetes subjects levels of each glucose molecule acti-
vity changed at different time-points by means of measured 
intensities of the peaks at 1041 cm
-1, 1080 cm
-1, 1118 cm
-1 
and 1153 cm
-1. Moreover, based on the intensities of the 
peaks at 1041 cm
-1 and 1118 cm
-1 we could again recognise 
2 spectral patterns in monitored spectra of healthy and diabe-
tes subjects. 
 Fig.  (4) shows clear differences between mean values of 
the peak near 1030 cm
-1 in a dose-dependent manner, mea-
sured in the patient with type 2 diabetes during a 30-minute 
OGTT monitoring after taking 5g, 20 g and 75 g of glucose 
orally. Identification and Characterization of Skin Biomolecules  The Open Medicinal Chemistry Journal, 2008, Volume 2    41 
Fiberoptic NIR FT Raman Spectroscopy for Molecular 
Diagnosis and In Vivo Monitoring of Inflammation in the 
Skin of Patch Tested Patients with Contact Dermatitis 
  The most significant changes in the spectra were detected 
in the regions specific for water content (2800-3400 cm
-1) 
and protein structure (600-1800 cm
-1)
 in all positive PT reac-
tions at 48 h and 72 h, when compared to normal skin. 
Fig. (2). Example of non-invasive glucose monitoring in the patient 
with type 2 diabetes by means of calculated intensities of the peak 
near 1030 cm
-1, that are indirectly followed by blood glucose level 
changes (shown in numbers along the line at determined time inter-
vals) [11, copyright permission for reproduction is obtained]. 
  Based on these spectral changes, primarily spectra of all 
positive PT reactions were divided into 2 groups: mean spec-
tra of irritant (IR), doubtful (+?) and weak (+) positive PT 
reactions and mean spectra of strong (++) and extremely 
strong (+++) positive PT reactions (Fig. 5a-b and Fig. 6a-b). 
By means of measured differences in absolute values of the 
3250 cm
-1 peak (ratio I3250/I2940) mean Raman spectra of [IR; 
+?; +] positive PT reactions were calculated as 0.37 (normal 
control) < 0.42 ( 48 h) < 0.51 (72 h), and mean Raman spec-
tra of [++; +++] were calculated as 0.37 (normal control) < 
0.59 (48 h) < 0.58 (72 h) (Fig. 5a-b). Protein structure 
changes differed mostly between 2 groups of positive PT 
reactions after 72 h, showing stable decrease at 48 h and 72 h 
at 1244 cm
-1 (amide III) and at 937 cm
-1 (protein backbone 
vibration) for the [++; +++]-group and coming back to nor-
mal at 72 h after transient decrease at 48 h for [IR; +?; +]-
group (Fig. 6a-b). 
  The measurement of water content with further calcula-
tion of the ratio I3250/I2940 for mean degrees of all reactions 
was 0.31 (-) < 0.34 (+?) < 0.41 (+) < 0.59 (++/+++) at 48 h 
and 0.31 (-) < 0.40 (+?) < 0.44 (+) < 0.69 (++/+++) at 72 h. 
The results of the Mann-Whitney U-test showed significant 
differences between (-) and (+?) [p < 0.03/48 h], (+?) and (+) 
[p < 0.04/48 h; p < 0.01/72 h], (+) and (++/+++) [p < 0.01/48 
h; p < 0.01/72h], but not between negative and doubtful PT 
reactions [p > 0.05] at 72 h [12] (Fig. 7a-b). 
FT-IR Microspectroscopy for In Vitro Molecular De-
scription of Skin Cancerous Tissue 
  Representative FT-IR spectra in the 800-1750 cm
-1 region
 
of epidermal premalignant (Bowen`s disease, solar kerato-
 
Fig. (1). Two spectral patterns: pattern 1 for prediabetes (blue line)/diabetes (black line) (I1118 > I1041) and pattern 2 for a healthy subject  
(yellow line) (I1118 < I1041). 
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sis), malignant (SCC, BCC, MM) tumours and dermal be-
nign (nevi) lesions, in comparison to normal epidermal and 
dermal skin components showed specific and similar pro-
gression towards malignancy spectral features: absorption 
between 1000 and 1150 cm
-1 seemed to correlate with a 
variation of the amide I1600-1700 / amide II 1480-1575 intensity 
ratio; the spectral features due to DNA and amide III (965 
cm
-1, 1071 cm
-1, 1084 cm
-1, 1095 cm
-1, 1245 cm
-1) have been 
modified and enhanced with progression to malignancy. 
These are shown in Fig. (8a-d). 
 
 
 
Fig. (3a-c). Examples of non-invasive monitoring of the activities 
of skin glucose biomolecules at around 1041 cm
-1, 1080 cm
-1, 1118 
cm
-1 and 1153 cm
-1 in the healthy (a), prediabetes (b) and diabetes 
(c) subjects during a 1-hour OGTT (75 g) at a 15-minute assess-
ments.  
 
Fig. (3d). Blood glucose levels of healthy, prediabetes and diabetes 
subjects during a 1-hour OGTT (75 g) with assessment every 15 
minutes. 
 
Fig. (4). In vivo monitored increased absorbances of the peak at 
1030 cm
-1 correlated with different oral doses of glucose (5 g, 20 g, 
75 g) and blood glucose level changes assessed at 30 min of 
OGTTs in the patient with type 2 diabetes [11, copyright permis-
sion for reproduction is obtained]. 
DISCUSSION 
  Our studies demonstrate that applied vibrational spec-
troscopy techniques for identification, characterization and 
monitoring of skin biomolecules were not only able to non-
invasively identify and comparatively characterize qualita-
tively and quantitatively skin biomolecules in described skin 
diseases and conditions, but were also able to continuously 
monitor pathophysiological processes in the skin with regard 
to the assessment of studied skin diseases and conditions, 
and their activity and severity at the molecular level. 
  Although both IR and Raman vibrational spectroscopy 
techniques are shown to be complementary in identification, 
characterization and monitoring of skin biomolecules in a 
rapid, objective and reliable way, the results of our studies 
certainly demonstrate the relative advantages and disadvan-
tages for measuring described skin diseases and conditions in 
vitro or in vivo. 
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  In detail, due to the fact that Raman spectroscopy can be 
easily applied for the analysis of watery biological samples 
and due to its demonstrated potential to in vitro characterize 
structure of water, proteins, lipids and other biomolecules in 
intact skin [3, 7], fiberoptic NIR FT Raman spectroscopy 
was applied to characterize water and proteins in in vivo 
monitored inflammed skin directly on the back of the patch 
tested patients with contact dermatitis. The sensitivity of this 
method was exploited not only to characterize molecular 
changes that occurred in skin type IV allergic reactions, but 
   
 
Fig. (5a-b). In vivo NIR FT Raman spectra (mean) in the range of 2500 cm
-1 to 3500 cm
-1 of normal skin (line a) [++; +++] (Fig. 5a) / [+?; 
+?/+; +] scored PT reactions (Fig. 5b) at 48 h (line b) and at 72 h (line c). The band at 3250 cm
-1 is indicated with an arrow [14, copyright 
permission for reproduction is obtained]. 44    The Open Medicinal Chemistry Journal, 2008, Volume 2  Eikje et al. 
also to monitor these molecular changes as skin progressed 
from normal to inflamed, as a result of the delayed contact 
hypersensitivity after application of allergens epicutaneously 
in patch tests [8, 13, 14]. 
  Chemical reactions and properties are important in the 
processes of developing delayed contact hypersensitivity, 
since it is the interaction of chemicals with self-proteins that 
drives the delayed allergic response in the skin. In order to 
cause skin sensitization, a chemical has to penetrate into the 
 
 
Fig. (6a-b). In vivo NIR-FT Raman spectra over the wavenumber range of 600 to 1800 cm
-1 of normal skin (line a) [++; +++] (Fig. 6a) / [+?; 
+?/+; +] scored PT reactions (Fig. 6b) at 48 h (line b) and at 72 h (line c). The bands of collagen amide III at 1244 cm
-1 and protein backbone 
vibration at 937 cm
-1 are indicated with arrows [14, copyright permission for reproduction is obtained]. Identification and Characterization of Skin Biomolecules  The Open Medicinal Chemistry Journal, 2008, Volume 2    45 
epidermis and bind to skin components [16, 17]. That was 
seen in our spectral results on protein structure changes, sta-
ble for allergic reactions and transient for irritant, possibly 
suggesting that amide III and protein backbone vibration 
could be such allergen-binding proteins [unpublished data]. 
  Moreover, by NIR FT Raman spectroscopy with a remote 
fiber optic probe the inflammatory oedema of the skin was 
assessed by means of identification and measurement of ab-
solute values of the 3250 cm
-1, specific for water amount and 
proportional to water content changes in the skin [8]. Based 
on these calculated differences in various degree of oedema 
in patch tested skin we were able to continuously monitor the 
gradual increase of water content in the skin, from the mini-
mal to the most severe, thus providing evidence of suitability 
of this method for clinical applications [13]. 
  The latter is also confirmed by the fact that in Raman 
spectra of the skin the majority of Raman scattering light is 
gathered from the dermis [18], where inflammatory oedema 
is mainly found. This is also because of the absorption of the 
long-wave excitation laser (1064 nm) and NIR Raman radia-
tion in deeper layers of the skin tissue, thus making perfectly 
possible in vivo measurements of patch test reactions on the 
back of the patients, where the thickness of normal skin is 
approximately 4 mm [19]. With a remote fiber optic probe 
attached, that uses the measuring aperture area of 8 mm in 
diameter, the patch test size of 1 cm
2 was analyzed entirely 
in our study [8]. 
  All these makes fiberoptic NIR Raman spectroscopy far 
superior for medical applications not only to clinically inves-
tigate cutaneous water distribution and structure by means of 
identification, characterization and monitoring of water bio-
molecules in the diseased conditions, but also to in vivo 
study of essentially unknown molecular mechanisms of con-
tact dermatitis/eczema directly on the patients. 
  IR light has limited opportunities for tissue penetration, 
but it has an advantage over Raman spectroscopy to charac-
terize in IR spectra molecules of the nucleic acids and glu-
cose [1]. Due to that, we probed FT-IR microspectroscopy to 
molecularly characterize skin cancerous tissue in vitro and 
ATR-FTIR spectroscopy to characterize skin glucose mole-
cules in the skin in vivo. 
  Although all biomolecules are important, the nucleic   
acids DNA and RNA are especially important because they 
carry within their structure the hereditary information that 
determines the identity and structure of proteins [1]. They 
play an important role in carcinogenesis. Understanding the 
molecular, cellular and tissue changes that occur during skin 
carcinogenesis is central to cancer research in dermatology. 
The translational aspects of this field – the development of 
clinical applications in dermatology from the laboratory 
findings – aim at improving clinical diagnosis, monitoring 
and treatment of skin cancer [3]. Clinically differential diag-
nosis of skin tumours is often difficult and a histopathologi-
cal diagnosis remains the “gold standard” [1, 3]. IR mic-
rospectroscopy has already been reported to make a correla-
tion between spectra and histology, with the additional ad-
vantage that IR spectra is sensitive toward differentiation, 
maturation, cell cycle dependence and state of health of cells 
in tissue [3]. The results of our study on molecular charac-
terization of several benign, premalignant and malignant skin 
tumours showed not only distinct differences in the shape 
and position of the nucleic acid absorptions, but also a sig-
nificant increase in intensities with progression to malig-
nancy. Alterations were also observed in the regions respon-
sible for proteins, which seemed to correlate with the varia-
tion of absorption of the peaks in the 1000-1150 cm
-1 region, 
responsible for DNA and amide III [15]. Therefore, it is most 
probable that malignant transformation triggers similar mo-
lecular changes. 
  With respect to complexity of IR spectra, even within 
grouped lesion categories, against huge inter- and intra-
sample variability, FT-IR microspectroscopy has demon-
strated an extremely high sensitivity not only to molecularly 
characterize skin cancerous tissue, but also to detect changes 
specific for carcinogenesis [15]. 
  ATR-FTIR spectroscopy is an established method to 
study molecular components and their differences in the up-
permost layer of the skin, stratum corneum, in vivo [20].   
 
 
Fig. (7a-b). Mean relative water content values and SD in contrast to visual gradings of PT reactions at 48 h (a) and at 72 h (b). 
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Fig. (8a-d). Representative FT-IR spectra over the wavenumber range from 800 to 1750 cm
-1 of epidermal premalignant (Bowen`s disease, 
solar keratosis), malignant (SCC, BCC, MM) tumours and dermal benign (nevi) lesions, in comparison to normal epidermal and dermal skin 
components [15, copyright permission for reproduction is obtained]. 
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Although early studies intensively describe in vivo regional 
variations  and depth-dependent non-homogeneity in the 
1000-4000 cm
-1 region, so far the glucose-specific region 
between 1000 cm
-1 and 1180 cm
-1  has not been fully de-
scribed in the literature. [11] In our study HATR-FTIR has 
been probed to in vivo identify and characterize molecules of 
glucose in the skin tissue from the inner wrists of measured 
non-diabetes and (pre-)diabetes subjects. 
  Spectral results from 7 healthy subjects identified glucose-
specific peaks at about 1030 cm
-1, 1041 cm
-1, 1080 cm
-1, 1118 
cm
-1 and 1153 cm
-1 under different screening test conditions. 
Although IR spectra of studied absorbances of glucose at a 
wavelength of 1030 cm
-1 is well-known for its good correla-
tion with a range of glucose concentrations in vitro [11], the 
behaviour of that glucose molecule in the skin in vivo is re-
mained to be elucidated [unpublished data]. Nevertheless, 
the previous study shows evidence of the possibility not only 
to assess glucose activity levels in the skin by means of cal-
culating the 1030 cm
-1 peak intensity values in measured 
spectra in vivo, but also to determine its changes in a dose-
dependent manner [11]. 
  Among 11 subjects another two prominent glucose-
specific peaks at 1041 cm
-1 and 1118 cm
-1 were identified 
and showed differences in their intensities in the measured 
spectra of non-diabetes, prediabetes and diabetes subjects. 
Based on that, two spectral patterns were seen for non-
diabetes and for (pre-)diabetes subjects: I1118 < I1041 for 
healthy, and I1118 > I1041 for prediabetes and diabetes subjects. 
  In the present study ATR-FTIR spectroscopy has also 
demonstrated its potential to in vivo simultaneously monitor 
glucose-specific peaks at 1030 cm
-1, 1041 cm
-1, 1080 cm
-1, 
1118 cm
-1 and 1153 cm
-1 at different time intervals and after 
intake of different doses of glucose. Our shown results sug-
gest that by means of measuring intensities of these peaks in 
the skin tissue we could not only determine differences in 
glucose activity levels in the skin of each subject, but could 
also to characterize and differentiate the activity of each glu-
cose molecule between healthy, prediabetes and diabetes 
subjects in real time. 
CONCLUSION 
  The results of the presented studies clearly demonstrate 
how vibrational spectroscopy techniques can be applied for 
identification, characterization and monitoring of several 
skin biomolecules in certain skin diseases and conditions, 
thus showing new possibilities to assess activity and severity 
of inflammation, activity of processes of carcinogenesis to-
wards progression to malignancy, and activity levels of glu-
cose metabolism in the skin tissue of healthy, prediabetes 
and diabetes subjects. 
FUTURE ASPECTS 
  Although vibrational spectroscopy techniques has already 
started to be recognized with regard to their potentials to 
molecularly characterize and monitor numerous diseases and 
conditions, new fields of applications are still to be found. 
Among those are how to implement these techniques for 
direct real-time therapeutic interventions, based on already 
received information on molecular aspects of the diseases; 
how to monitor the effects of therapies based on molecular 
monitoring of severity and activity of pathological condi-
tions and processes; and how to use normal and diseased 
vibrational spectra information for individualization of drug 
or treatment. Only the focused research and development of 
applications to further identify, characterize and monitor skin 
diseases and conditions undescribed at the molecular level 
will provide future ability to treat and control not only can-
cers, eczema and carbohydrate metabolism disorders, but 
also many others that await their medical needs and scien-
tific opportunities. 
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